Skip to main content
Equibles

Carnegie Investment Counsel

Position in AVXL — Anavex Life Sciences Corp.

CIK 1511506 PEPPER PIKE, OH
Back to AVXL Full portfolio

Position in AVXL

as of Jun 30, 2026 · filed Jul 30, 2026
Position Value
$99,010
-$108,454 QoQ
Shares Held
38,228
-43.4% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 179 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVXL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Carnegie Investment Counsel holds $232,130 across 2 Biotechnology names. AVXL ranks #2 (42.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IOVA
Iovance Biotherapeutics, Inc.
 32,000 $133,120
2 AVXL
Anavex Life Sciences Corp.
This page 		38,228 $99,010

All Filings in AVXL

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $99,010 38,228
2026-03-31 $207,464 67,578
2025-12-31 $240,577 67,578
2025-09-30 $736,724 82,778
2025-06-30 $763,213 82,778
2025-03-31 $710,235 82,778
2024-12-31 $824,595 76,778
2024-09-30 $416,531 73,333
2024-06-30 $309,465 73,333
2024-03-31 $373,264 73,333
2023-12-31 $685,774 73,660
2023-09-30 $441,535 67,410
2023-06-30 $553,327 68,060
2023-03-31 $374,294 43,675
2022-12-31 $173,625 18,750